25 XP   0   0   10

Quoin Pharmaceuticals Ltd DRC
Buy, Hold or Sell?

Let's analyse Quoin Pharmaceuticals Ltd DRC together

PenkeI guess you are interested in Quoin Pharmaceuticals Ltd DRC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Quoin Pharmaceuticals Ltd DRC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Quoin Pharmaceuticals Ltd DRC

I send you an email if I find something interesting about Quoin Pharmaceuticals Ltd DRC.

Quick analysis of Quoin Pharmaceuticals Ltd DRC (30 sec.)










What can you expect buying and holding a share of Quoin Pharmaceuticals Ltd DRC? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
6.3%

What is your share worth?

Current worth
$1.54
Expected worth in 1 year
$1.06
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-0.47
Return On Investment
-74.2%

For what price can you sell your share?

Current Price per Share
$0.64
Expected price per share
$0 - $2.2507
How sure are you?
50%

1. Valuation of Quoin Pharmaceuticals Ltd DRC (5 min.)




Live pricePrice per Share (EOD)

$0.64

Intrinsic Value Per Share

$-48.34 - $-57.43

Total Value Per Share

$-46.81 - $-55.89

2. Growth of Quoin Pharmaceuticals Ltd DRC (5 min.)




Is Quoin Pharmaceuticals Ltd DRC growing?

Current yearPrevious yearGrowGrow %
How rich?$5.6m$3.5m$4.7m57.5%

How much money is Quoin Pharmaceuticals Ltd DRC making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m-$5.3b$5.3b252,729.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Quoin Pharmaceuticals Ltd DRC (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#731 / 1010

Most Revenue
#737 / 1010

Most Profit
#307 / 1010

Most Efficient
#267 / 1010

What can you expect buying and holding a share of Quoin Pharmaceuticals Ltd DRC? (5 min.)

Welcome investor! Quoin Pharmaceuticals Ltd DRC's management wants to use your money to grow the business. In return you get a share of Quoin Pharmaceuticals Ltd DRC.

What can you expect buying and holding a share of Quoin Pharmaceuticals Ltd DRC?

First you should know what it really means to hold a share of Quoin Pharmaceuticals Ltd DRC. And how you can make/lose money.

Speculation

The Price per Share of Quoin Pharmaceuticals Ltd DRC is $0.6375. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Quoin Pharmaceuticals Ltd DRC.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Quoin Pharmaceuticals Ltd DRC, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.54. Based on the TTM, the Book Value Change Per Share is $-0.12 per quarter. Based on the YOY, the Book Value Change Per Share is $0.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Quoin Pharmaceuticals Ltd DRC.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.56-88.2%-0.56-87.4%-0.64-100.5%-0.49-76.4%-0.49-76.4%
Usd Book Value Change Per Share-0.47-74.5%-0.12-18.5%0.5078.8%0.1015.1%0.1015.1%
Usd Dividend Per Share0.000.0%0.000.0%4.43694.4%1.11173.6%1.11173.6%
Usd Total Gains Per Share-0.47-74.5%-0.12-18.5%4.93773.2%1.20188.7%1.20188.7%
Usd Price Per Share4.91-2.51-1.36-3.22-3.22-
Price to Earnings Ratio-2.18--1.15--0.55--3,816.78--3,816.78-
Price-to-Total Gains Ratio-10.33--5.01-1.94--4.77--4.77-
Price to Book Ratio3.19-1.40-2.14-274,390.46-274,390.46-
Price-to-Total Gains Ratio-10.33--5.01-1.94--4.77--4.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.6375
Number of shares1568
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.001.11
Usd Book Value Change Per Share-0.120.10
Usd Total Gains Per Share-0.121.20
Gains per Quarter (1568 shares)-185.341,885.84
Gains per Year (1568 shares)-741.357,543.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-741-75169416027533
20-1483-149213882120515076
30-2224-223320823180722619
40-2965-297427764240930162
50-3707-371534705301237705
60-4448-445641646361445248
70-5189-519748587421752791
80-5931-593855528481960334
90-6672-667962469542167877
100-7413-742069410602475420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.016.00.00.0%0.016.00.00.0%0.016.00.00.0%
Book Value Change Per Share1.03.00.025.0%4.07.01.033.3%5.08.03.031.3%5.08.03.031.3%5.08.03.031.3%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.015.06.3%1.00.015.06.3%1.00.015.06.3%
Total Gains per Share1.03.00.025.0%5.06.01.041.7%6.07.03.037.5%6.07.03.037.5%6.07.03.037.5%

Fundamentals of Quoin Pharmaceuticals Ltd DRC

About Quoin Pharmaceuticals Ltd DRC

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.

Fundamental data was last updated by Penke on 2024-04-25 12:04:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Quoin Pharmaceuticals Ltd DRC.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Quoin Pharmaceuticals Ltd DRC earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Quoin Pharmaceuticals Ltd DRC to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Quoin Pharmaceuticals Ltd DRC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--216.8%+216.8%
YOY--282.3%+282.3%
5Y--436.8%+436.8%
10Y--597.3%+597.3%
1.1.2. Return on Assets

Shows how efficient Quoin Pharmaceuticals Ltd DRC is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Quoin Pharmaceuticals Ltd DRC to the Biotechnology industry mean.
  • -17.0% Return on Assets means that Quoin Pharmaceuticals Ltd DRC generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Quoin Pharmaceuticals Ltd DRC:

  • The MRQ is -17.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.0%TTM-13.8%-3.2%
TTM-13.8%YOY-57,352.9%+57,339.1%
TTM-13.8%5Y-14,383.2%+14,369.4%
5Y-14,383.2%10Y-14,383.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.0%-13.3%-3.7%
TTM-13.8%-12.8%-1.0%
YOY-57,352.9%-11.6%-57,341.3%
5Y-14,383.2%-13.8%-14,369.4%
10Y-14,383.2%-15.6%-14,367.6%
1.1.3. Return on Equity

Shows how efficient Quoin Pharmaceuticals Ltd DRC is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Quoin Pharmaceuticals Ltd DRC to the Biotechnology industry mean.
  • -36.6% Return on Equity means Quoin Pharmaceuticals Ltd DRC generated $-0.37 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Quoin Pharmaceuticals Ltd DRC:

  • The MRQ is -36.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -26.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-36.6%TTM-26.9%-9.7%
TTM-26.9%YOY-816,435.2%+816,408.3%
TTM-26.9%5Y-204,227.9%+204,201.0%
5Y-204,227.9%10Y-204,227.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.6%-16.9%-19.7%
TTM-26.9%-16.1%-10.8%
YOY-816,435.2%-14.9%-816,420.3%
5Y-204,227.9%-19.3%-204,208.6%
10Y-204,227.9%-20.1%-204,207.8%

1.2. Operating Efficiency of Quoin Pharmaceuticals Ltd DRC.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Quoin Pharmaceuticals Ltd DRC is operating .

  • Measures how much profit Quoin Pharmaceuticals Ltd DRC makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Quoin Pharmaceuticals Ltd DRC to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Quoin Pharmaceuticals Ltd DRC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY--288.4%+288.4%
5Y--486.2%+486.2%
10Y--628.4%+628.4%
1.2.2. Operating Ratio

Measures how efficient Quoin Pharmaceuticals Ltd DRC is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Quoin Pharmaceuticals Ltd DRC:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM-3.310-3.310
YOY-3.838-3.838
5Y-5.679-5.679
10Y-7.823-7.823

1.3. Liquidity of Quoin Pharmaceuticals Ltd DRC.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Quoin Pharmaceuticals Ltd DRC is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.15 means the company has $3.15 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Quoin Pharmaceuticals Ltd DRC:

  • The MRQ is 3.151. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.492. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.151TTM3.492-0.341
TTM3.492YOY2.520+0.972
TTM3.4925Y4.448-0.956
5Y4.44810Y4.4480.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1513.863-0.712
TTM3.4924.169-0.677
YOY2.5205.337-2.817
5Y4.4486.122-1.674
10Y4.4486.434-1.986
1.3.2. Quick Ratio

Measures if Quoin Pharmaceuticals Ltd DRC is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Quoin Pharmaceuticals Ltd DRC to the Biotechnology industry mean.
  • A Quick Ratio of 5.30 means the company can pay off $5.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Quoin Pharmaceuticals Ltd DRC:

  • The MRQ is 5.302. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.997. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.302TTM5.997-0.695
TTM5.997YOY3.760+2.237
TTM5.9975Y5.364+0.632
5Y5.36410Y5.3640.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3023.504+1.798
TTM5.9973.991+2.006
YOY3.7605.371-1.611
5Y5.3646.088-0.724
10Y5.3646.395-1.031

1.4. Solvency of Quoin Pharmaceuticals Ltd DRC.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Quoin Pharmaceuticals Ltd DRC assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Quoin Pharmaceuticals Ltd DRC to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.53 means that Quoin Pharmaceuticals Ltd DRC assets are financed with 53.5% credit (debt) and the remaining percentage (100% - 53.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Quoin Pharmaceuticals Ltd DRC:

  • The MRQ is 0.535. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.477. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.535TTM0.477+0.058
TTM0.477YOY0.898-0.421
TTM0.4775Y2.122-1.645
5Y2.12210Y2.1220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5350.339+0.196
TTM0.4770.337+0.140
YOY0.8980.271+0.627
5Y2.1220.368+1.754
10Y2.1220.388+1.734
1.4.2. Debt to Equity Ratio

Measures if Quoin Pharmaceuticals Ltd DRC is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Quoin Pharmaceuticals Ltd DRC to the Biotechnology industry mean.
  • A Debt to Equity ratio of 114.9% means that company has $1.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Quoin Pharmaceuticals Ltd DRC:

  • The MRQ is 1.149. The company is able to pay all its debts with equity. +1
  • The TTM is 0.928. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.149TTM0.928+0.220
TTM0.928YOY3.747-2.818
TTM0.9285Y1.996-1.068
5Y1.99610Y1.9960.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1490.392+0.757
TTM0.9280.403+0.525
YOY3.7470.335+3.412
5Y1.9960.427+1.569
10Y1.9960.461+1.535

2. Market Valuation of Quoin Pharmaceuticals Ltd DRC

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Quoin Pharmaceuticals Ltd DRC generates.

  • Above 15 is considered overpriced but always compare Quoin Pharmaceuticals Ltd DRC to the Biotechnology industry mean.
  • A PE ratio of -2.18 means the investor is paying $-2.18 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Quoin Pharmaceuticals Ltd DRC:

  • The EOD is -0.284. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.181. Based on the earnings, the company is expensive. -2
  • The TTM is -1.148. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.284MRQ-2.181+1.898
MRQ-2.181TTM-1.148-1.033
TTM-1.148YOY-0.550-0.598
TTM-1.1485Y-3,816.780+3,815.632
5Y-3,816.78010Y-3,816.7800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.284-2.300+2.016
MRQ-2.181-2.656+0.475
TTM-1.148-2.718+1.570
YOY-0.550-4.145+3.595
5Y-3,816.780-6.258-3,810.522
10Y-3,816.780-6.315-3,810.465
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Quoin Pharmaceuticals Ltd DRC:

  • The EOD is -0.180. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.386. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.206. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.180MRQ-1.386+1.206
MRQ-1.386TTM-1.206-0.180
TTM-1.206YOY-0.551-0.655
TTM-1.2065Y-13,148.493+13,147.287
5Y-13,148.49310Y-13,148.4930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.180-2.974+2.794
MRQ-1.386-3.306+1.920
TTM-1.206-3.508+2.302
YOY-0.551-5.613+5.062
5Y-13,148.493-8.378-13,140.115
10Y-13,148.493-8.873-13,139.620
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Quoin Pharmaceuticals Ltd DRC is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.19 means the investor is paying $3.19 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Quoin Pharmaceuticals Ltd DRC:

  • The EOD is 0.415. Based on the equity, the company is cheap. +2
  • The MRQ is 3.192. Based on the equity, the company is fair priced.
  • The TTM is 1.405. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.415MRQ3.192-2.777
MRQ3.192TTM1.405+1.787
TTM1.405YOY2.135-0.730
TTM1.4055Y274,390.456-274,389.051
5Y274,390.45610Y274,390.4560.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.4151.914-1.499
MRQ3.1922.116+1.076
TTM1.4052.097-0.692
YOY2.1352.881-0.746
5Y274,390.4563.550+274,386.906
10Y274,390.4563.936+274,386.520
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Quoin Pharmaceuticals Ltd DRC.

3.1. Institutions holding Quoin Pharmaceuticals Ltd DRC

Institutions are holding 2.296% of the shares of Quoin Pharmaceuticals Ltd DRC.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Susquehanna International Group, LLP2.1239020968209680
2023-12-31Rhumbline Advisers0.10770106315517.0705
2023-12-31Wells Fargo & Co000-8-100
2023-12-31UBS Group AG000-819-100
Total 2.2316022031+20296+92.1%

3.2. Funds holding Quoin Pharmaceuticals Ltd DRC

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Nasdaq Composite Index0.002609500
Total 0.002609500.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Quoin Pharmaceuticals Ltd DRC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.475-0.118-75%0.502-194%0.096-594%0.096-594%
Book Value Per Share--1.5372.243-31%0.954+61%1.112+38%1.112+38%
Current Ratio--3.1513.492-10%2.520+25%4.448-29%4.448-29%
Debt To Asset Ratio--0.5350.477+12%0.898-40%2.122-75%2.122-75%
Debt To Equity Ratio--1.1490.928+24%3.747-69%1.996-42%1.996-42%
Dividend Per Share----0%4.427-100%1.107-100%1.107-100%
Eps---0.562-0.557-1%-0.641+14%-0.487-13%-0.487-13%
Free Cash Flow Per Share---0.885-0.536-39%-0.662-25%-0.372-58%-0.372-58%
Free Cash Flow To Equity Per Share---0.920-0.178-81%0.994-193%0.217-524%0.217-524%
Gross Profit Margin--1.0071.002+1%1.000+1%1.000+1%1.000+1%
Intrinsic Value_10Y_max---57.430--------
Intrinsic Value_10Y_min---48.343--------
Intrinsic Value_1Y_max---2.428--------
Intrinsic Value_1Y_min---2.383--------
Intrinsic Value_3Y_max---9.831--------
Intrinsic Value_3Y_min---9.335--------
Intrinsic Value_5Y_max---20.291--------
Intrinsic Value_5Y_min---18.615--------
Market Cap2349805.875-669%18079682.8509243399.118+96%5003980.723+261%180294458834.529-100%180294458834.529-100%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.415-669%3.1921.405+127%2.135+49%274390.456-100%274390.456-100%
Pe Ratio-0.284+87%-2.181-1.148-47%-0.550-75%-3816.780+174875%-3816.780+174875%
Price Per Share0.638-669%4.9052.508+96%1.358+261%3.219+52%3.219+52%
Price To Free Cash Flow Ratio-0.180+87%-1.386-1.206-13%-0.551-60%-13148.493+948504%-13148.493+948504%
Price To Total Gains Ratio-1.343+87%-10.333-5.015-51%1.944-632%-4.772-54%-4.772-54%
Quick Ratio--5.3025.997-12%3.760+41%5.364-1%5.364-1%
Return On Assets---0.170-0.138-19%-573.529+336731%-143.832+84372%-143.832+84372%
Return On Equity---0.366-0.269-26%-8164.352+2231617%-2042.279+558155%-2042.279+558155%
Total Gains Per Share---0.475-0.118-75%4.929-110%1.203-139%1.203-139%
Usd Book Value--5664050.0008266015.250-31%3515840.000+61%4140018.813+37%4140018.813+37%
Usd Book Value Change Per Share---0.475-0.118-75%0.502-194%0.096-594%0.096-594%
Usd Book Value Per Share--1.5372.243-31%0.954+61%1.112+38%1.112+38%
Usd Dividend Per Share----0%4.427-100%1.107-100%1.107-100%
Usd Eps---0.562-0.557-1%-0.641+14%-0.487-13%-0.487-13%
Usd Free Cash Flow---3260917.000-1975425.250-39%-2441086.375-25%-1584360.594-51%-1584360.594-51%
Usd Free Cash Flow Per Share---0.885-0.536-39%-0.662-25%-0.372-58%-0.372-58%
Usd Free Cash Flow To Equity Per Share---0.920-0.178-81%0.994-193%0.217-524%0.217-524%
Usd Market Cap2349805.875-669%18079682.8509243399.118+96%5003980.723+261%180294458834.529-100%180294458834.529-100%
Usd Price Per Share0.638-669%4.9052.508+96%1.358+261%3.219+52%3.219+52%
Usd Profit---2072095.000-2122467.750+2%-5366226238.000+258876%-1343517792.000+64739%-1343517792.000+64739%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.475-0.118-75%4.929-110%1.203-139%1.203-139%
 EOD+3 -5MRQTTM+7 -23YOY+18 -145Y+11 -2110Y+11 -21

4.2. Fundamental Score

Let's check the fundamental score of Quoin Pharmaceuticals Ltd DRC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.284
Price to Book Ratio (EOD)Between0-10.415
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.302
Current Ratio (MRQ)Greater than13.151
Debt to Asset Ratio (MRQ)Less than10.535
Debt to Equity Ratio (MRQ)Less than11.149
Return on Equity (MRQ)Greater than0.15-0.366
Return on Assets (MRQ)Greater than0.05-0.170
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Quoin Pharmaceuticals Ltd DRC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5019.587
Ma 20Greater thanMa 500.753
Ma 50Greater thanMa 1001.329
Ma 100Greater thanMa 2002.742
OpenGreater thanClose0.630
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income Tax Expense  -26-193-21931-188164-242,0962,072



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets12,169
Total Liabilities6,505
Total Stockholder Equity5,664
 As reported
Total Liabilities 6,505
Total Stockholder Equity+ 5,664
Total Assets = 12,169

Assets

Total Assets12,169
Total Current Assets11,286
Long-term Assets883
Total Current Assets
Cash And Cash Equivalents 2,401
Short-term Investments 8,294
Other Current Assets 591
Total Current Assets  (as reported)11,286
Total Current Assets  (calculated)11,286
+/- 0
Long-term Assets
Intangible Assets 583
Long-term Assets Other 300
Long-term Assets  (as reported)883
Long-term Assets  (calculated)883
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,582
Long-term Liabilities2,924
Total Stockholder Equity5,664
Total Current Liabilities
Short-term Debt 1
Accounts payable 527
Other Current Liabilities 3,054
Total Current Liabilities  (as reported)3,582
Total Current Liabilities  (calculated)3,582
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)2,924
Long-term Liabilities  (calculated)0
+/- 2,924
Total Stockholder Equity
Retained Earnings -46,204
Other Stockholders Equity 51,868
Total Stockholder Equity (as reported)5,664
Total Stockholder Equity (calculated)5,664
+/-0
Other
Cash and Short Term Investments 10,695
Common Stock Shares Outstanding 987
Current Deferred Revenue-1
Liabilities and Stockholders Equity 12,169
Net Debt -2,398
Net Invested Capital 5,664
Net Working Capital 7,704
Short Long Term Debt Total 4



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312018-12-312017-12-312016-12-31
> Total Assets 
8,819
33,910
30,373
21,320
0
0
1,378
0
2,933
1,843
9,357
9,357
4,321
16,438
14,458
18,451
16,709
15,068
12,169
12,16915,06816,70918,45114,45816,4384,3219,3579,3571,8432,93301,3780021,32030,37333,9108,819
   > Total Current Assets 
1,633
6,279
13,734
18,106
0
0
465
1,372
2,022
959
8,498
8,498
3,515
15,658
13,370
17,389
15,674
14,141
11,286
11,28614,14115,67417,38913,37015,6583,5158,4988,4989592,0221,3724650018,10613,7346,2791,633
       Cash And Cash Equivalents 
1,633
6,279
13,734
18,106
0
0
324
0
1,721
653
7,483
7,483
2,688
5,250
2,861
3,372
4,759
3,163
2,401
2,4013,1634,7593,3722,8615,2502,6887,4837,4836531,72103240018,10613,7346,2791,633
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
9,911
9,993
13,618
10,680
10,818
8,294
8,29410,81810,68013,6189,9939,9110000000000000
       Other Current Assets 
0
0
0
0
0
0
0
246
302
306
1,015,474
1,015,474
827
497
517
14,017
10,914
10,978
591
59110,97810,91414,0175174978271,015,4741,015,4743063022460000000
   > Long-term Assets 
357
1,373
1,344
2,323
0
0
913
0
911
885
859
859
807
781
1,088
1,062
1,036
927
883
8839271,0361,0621,0887818078598598859110913002,3231,3441,373357
       Property Plant Equipment 
357
1,373
1,344
2,323
0
0
1,937
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,937002,3231,3441,373357
       Intangible Assets 
0
0
0
0
0
0
913
0
861
835
809
809
757
731
705
679
653
627
583
5836276536797057317578098098358610913000000
       Long-term Assets Other 
0
0
0
0
0
0
-1,937
0
50
50
50
50
50
50
383
383
383
300
300
3003003833833835050505050500-1,937000000
> Total Liabilities 
0
0
0
396
0
0
7,985
0
17,782
18,096
8,700
8,700
7,489
7,271
7,051
7,536
7,638
7,654
6,505
6,5057,6547,6387,5367,0517,2717,4898,7008,70018,09617,78207,98500396000
   > Total Current Liabilities 
0
0
0
396
0
0
7,985
10,323
13,112
13,573
8,700
8,700
3,666
3,597
3,528
4,163
4,414
4,580
3,582
3,5824,5804,4144,1633,5283,5973,6668,7008,70013,57313,11210,3237,98500396000
       Short-term Debt 
0
0
0
396
0
0
1,213
0
6,213
6,213
743,840
743,840
0
0
0
1
1
1
1
1111000743,840743,8406,2136,21301,21300396000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
6,213
6,213
0
0
0
0
0
0
0
0
0
0000000006,2136,21300000000
       Accounts payable 
0
0
0
0
0
0
0
235
404
518
923
923
769
281
606
281
708
240
527
5272407082816062817699239235184042350000000
       Other Current Liabilities 
0
0
0
0
0
0
6,772
1,652
6,330
38
374
374
2,897
3,316
2,922
3,881
3,705
4,340
3,054
3,0544,3403,7053,8812,9223,3162,897374374386,3301,6526,772000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
4,670
4,523
7,032,740
7,032,740
3,824
3,674
3,524
3,374
3,224
3,074
2,924
2,9243,0743,2243,3743,5243,6743,8247,032,7407,032,7404,5234,67000000000
       Other Liabilities 
0
0
0
0
0
0
0
2,447
4,670
4,523
374
0
0
0
0
0
0
0
0
000000003744,5234,6702,4470000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
50
50
0
0
0
50
0
383
383
0
0
00383383050000505000000000
> Total Stockholder Equity
7,409
28,487
18,852
0
0
0
-6,607
0
-14,849
-16,253
657
657
-3,168
9,168
7,407
10,914
9,072
7,414
5,664
5,6647,4149,07210,9147,4079,168-3,168657657-16,253-14,8490-6,60700018,85228,4877,409
   Common Stock
0
0
0
0
0
0
0
0
0
0
31,659
0
0
0
0
-2,932
-2,932
0
0
00-2,932-2,932000031,6590000000000
   Retained Earnings Total Equity0000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
7,409
28,487
18,852
100,864
0
0
0
0
0
0
28,727
28,727
29,253
44,683
44,924
51,034
54,231
54,499
51,868
51,86854,49954,23151,03444,92444,68329,25328,72728,727000000100,86418,85228,4877,409



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-103
Gross Profit-103-103
 
Operating Income (+$)
Gross Profit-103
Operating Expense-9,251
Operating Income-9,354-9,354
 
Operating Expense (+$)
Research Development3,196
Selling General Administrative6
Selling And Marketing Expenses6,064,462
Operating Expense9,2516,067,664
 
Net Interest Income (+$)
Interest Income617
Interest Expense-0
Other Finance Cost-0
Net Interest Income617
 
Pretax Income (+$)
Operating Income-9,354
Net Interest Income617
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,664-10,044
EBIT - interestExpense = -9,354
0
-8,664
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-9,354-8,664
Earnings Before Interest and Taxes (EBITDA)-9,251
 
After tax Income (+$)
Income Before Tax-8,664
Tax Provision-0
Net Income From Continuing Ops-8,638-8,664
Net Income-8,664
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses9,354
Total Other Income/Expenses Net690-617
 

Technical Analysis of Quoin Pharmaceuticals Ltd DRC
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Quoin Pharmaceuticals Ltd DRC. The general trend of Quoin Pharmaceuticals Ltd DRC is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Quoin Pharmaceuticals Ltd DRC's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Quoin Pharmaceuticals Ltd DRC.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.8 < 0.9789 < 2.2507.

The bearish price targets are: .

Tweet this
Quoin Pharmaceuticals Ltd DRC Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Quoin Pharmaceuticals Ltd DRC. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Quoin Pharmaceuticals Ltd DRC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Quoin Pharmaceuticals Ltd DRC. The current macd is -0.18850899.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Quoin Pharmaceuticals Ltd DRC price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Quoin Pharmaceuticals Ltd DRC. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Quoin Pharmaceuticals Ltd DRC price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Quoin Pharmaceuticals Ltd DRC Daily Moving Average Convergence/Divergence (MACD) ChartQuoin Pharmaceuticals Ltd DRC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Quoin Pharmaceuticals Ltd DRC. The current adx is 12.18.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Quoin Pharmaceuticals Ltd DRC shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Quoin Pharmaceuticals Ltd DRC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Quoin Pharmaceuticals Ltd DRC. The current sar is 0.695056.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Quoin Pharmaceuticals Ltd DRC Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Quoin Pharmaceuticals Ltd DRC. The current rsi is 19.59. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Quoin Pharmaceuticals Ltd DRC Daily Relative Strength Index (RSI) ChartQuoin Pharmaceuticals Ltd DRC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Quoin Pharmaceuticals Ltd DRC. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Quoin Pharmaceuticals Ltd DRC price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Quoin Pharmaceuticals Ltd DRC Daily Stochastic Oscillator ChartQuoin Pharmaceuticals Ltd DRC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Quoin Pharmaceuticals Ltd DRC. The current cci is -118.74924414.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Quoin Pharmaceuticals Ltd DRC Daily Commodity Channel Index (CCI) ChartQuoin Pharmaceuticals Ltd DRC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Quoin Pharmaceuticals Ltd DRC. The current cmo is -63.01610909.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Quoin Pharmaceuticals Ltd DRC Daily Chande Momentum Oscillator (CMO) ChartQuoin Pharmaceuticals Ltd DRC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Quoin Pharmaceuticals Ltd DRC. The current willr is -83.14661471.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Quoin Pharmaceuticals Ltd DRC Daily Williams %R ChartQuoin Pharmaceuticals Ltd DRC Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Quoin Pharmaceuticals Ltd DRC.

Quoin Pharmaceuticals Ltd DRC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Quoin Pharmaceuticals Ltd DRC. The current atr is 0.09651716.

Quoin Pharmaceuticals Ltd DRC Daily Average True Range (ATR) ChartQuoin Pharmaceuticals Ltd DRC Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Quoin Pharmaceuticals Ltd DRC. The current obv is 27,057,470.

Quoin Pharmaceuticals Ltd DRC Daily On-Balance Volume (OBV) ChartQuoin Pharmaceuticals Ltd DRC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Quoin Pharmaceuticals Ltd DRC. The current mfi is 3.05616014.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Quoin Pharmaceuticals Ltd DRC Daily Money Flow Index (MFI) ChartQuoin Pharmaceuticals Ltd DRC Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Quoin Pharmaceuticals Ltd DRC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Quoin Pharmaceuticals Ltd DRC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Quoin Pharmaceuticals Ltd DRC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5019.587
Ma 20Greater thanMa 500.753
Ma 50Greater thanMa 1001.329
Ma 100Greater thanMa 2002.742
OpenGreater thanClose0.630
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Quoin Pharmaceuticals Ltd DRC with someone you think should read this too:
  • Are you bullish or bearish on Quoin Pharmaceuticals Ltd DRC? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Quoin Pharmaceuticals Ltd DRC? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Quoin Pharmaceuticals Ltd DRC

I send you an email if I find something interesting about Quoin Pharmaceuticals Ltd DRC.


Comments

How you think about this?

Leave a comment

Stay informed about Quoin Pharmaceuticals Ltd DRC.

Receive notifications about Quoin Pharmaceuticals Ltd DRC in your mailbox!